Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) - Cash on Hand
Cash on Hand as of December 2023 : $56.93 M
According to Rigel Pharmaceuticals's latest financial reports the company has $56.93 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Rigel Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $56.93 M | -2.19% |
| 2022-12-31 | $58.2 M | -53.42% |
| 2021-12-31 | $0.12 B | 117.99% |
| 2020-12-31 | $57.32 M | -41.55% |
| 2019-12-31 | $98.07 M | -23.7% |
| 2018-12-31 | $0.12 B | 11.05% |
| 2017-12-31 | $0.11 B | 54.82% |
| 2016-12-31 | $74.76 M | -40.79% |
| 2015-12-31 | $0.12 B | -11.79% |
| 2014-12-31 | $0.14 B | -32.46% |
| 2013-12-31 | $0.21 B | -28.92% |
| 2012-12-31 | $0.29 B | 20.43% |
| 2011-12-31 | $0.24 B | 39.68% |
| 2010-12-31 | $0.17 B | 32.99% |
| 2009-12-31 | $0.13 B | -0.86% |
| 2008-12-31 | $0.13 B | 24.18% |
| 2007-12-31 | $0.10 B | 3.66% |
| 2006-12-31 | $0.10 B | -24.4% |
| 2005-12-31 | $0.13 B | 93.48% |
| 2004-12-31 | $71.42 M | 53.61% |
| 2003-12-31 | $46.5 M | 70.39% |
| 2002-12-31 | $27.29 M | -18.33% |
| 2001-12-31 | $33.41 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $10.94 B | 19,122.59% | 🇺🇸 USA |
 AstraZeneca AZN | $8.02 B | 13,988.49% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $81 M | 42.28% | 🇺🇸 USA |
 ChemoCentryx CCXI | N/A | N/A | 🇺🇸 USA |